Due to network maintenance at the University of Basel, the SWISS-MODEL website will be interrupted this weekend between 07:00 CET Saturday 17th May and 23:55 CET Sunday 18th May.

Multiple Assemblies exist for SMTL entry 6fe7
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-356; X-RAY DIFFRACTION 2.00 Å

SMTL ID
6fe7.1
Ligands
ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; (4aS,8aR)-2-(1-{2-aminothieno[2,3-d]pyrimidin-4-yl}piperidin-4-yl)-4-(3,4- dimethoxyphenyl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6fe7.2
Ligands
ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; (4aS,8aR)-2-(1-{2-aminothieno[2,3-d]pyrimidin-4-yl}piperidin-4-yl)-4-(3,4- dimethoxyphenyl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6fe7.3
Ligands
1,2-ETHANEDIOL; TETRAETHYLENE GLYCOL; ZINC ION; MAGNESIUM ION; DI(HYDROXYETHYL)ETHER; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; (4aS,8aR)-2-(1-{2-aminothieno[2,3-d]pyrimidin-4-yl}piperidin-4-yl)-4-(3,4- dimethoxyphenyl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6fe7.4
Ligands
1,2-ETHANEDIOL; ZINC ION; MAGNESIUM ION; DI(HYDROXYETHYL)ETHER; (4aS,8aR)-2-(1-{2-aminothieno[2,3-d]pyrimidin-4-yl}piperidin-4-yl)-4-(3,4- dimethoxyphenyl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer